Skip to main content
. 2023 Feb 28;13(3):e1214. doi: 10.1002/ctm2.1214

FIGURE 2.

FIGURE 2

Kaplan–Meier curves of overall survival in the entire cohort (A) and in the propensity score‐matched cohort (B), and progression‐free survival in the entire cohort (C) and in the propensity score‐matched cohort (D) of patients with advanced hepatocellular carcinoma (HCC) beyond oligometastasis who were treated with lenvatinib plus programmed death receptor‐1 (PD‐1) inhibitor. CI, confidence interval; HR, hazard ratio.